Compare FNWB & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FNWB | DRIO |
|---|---|---|
| Founded | 1923 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 87.5M | 84.1M |
| IPO Year | 2015 | N/A |
| Metric | FNWB | DRIO |
|---|---|---|
| Price | $10.92 | $11.73 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $13.50 | ★ $50.00 |
| AVG Volume (30 Days) | ★ 51.2K | 15.1K |
| Earning Date | 01-23-2026 | 03-09-2026 |
| Dividend Yield | ★ 1.35% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $54,052,000.00 | $24,732,000.00 |
| Revenue This Year | $31.86 | N/A |
| Revenue Next Year | $10.64 | $18.61 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 6.47 | ★ 7.29 |
| 52 Week Low | $6.05 | $5.94 |
| 52 Week High | $12.10 | $17.74 |
| Indicator | FNWB | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 78.76 | 49.29 |
| Support Level | $9.59 | $11.77 |
| Resistance Level | $10.03 | $12.48 |
| Average True Range (ATR) | 0.27 | 0.84 |
| MACD | 0.11 | 0.05 |
| Stochastic Oscillator | 96.82 | 42.39 |
First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.